Point-of-Care Diagnostics Market Size:
Point-of-Care Diagnostics Market was valued at USD 46.97 billion in 2023 and is expected to reach USD 91.47 billion by 2032, growing at a CAGR of 7.72% from 2024-2032.
The point-of-care diagnostics market has experienced substantial expansion driven by the growing need for swift and precise diagnostic solutions that improve clinical decision-making and patient results. POC diagnostics allows for testing to be conducted at or close to the patient's site, providing faster results than conventional laboratory testing. This benefit has propelled their use in numerous applications, such as testing for infectious diseases, glucose levels, cardiac indicators, and pregnancy assessments.
Innovations in biosensors, microfluidics, and compact diagnostic tools have driven the market's development, enhancing device usability, portability, and efficiency. Recent advancements feature the emergence of AI-driven POC platforms, enhancing test precision and effectiveness. For example, in May 2023, BD obtained 510(k) approval for its Kiestra MRSA imaging application, utilizing AI to speed up test turnaround times. Likewise, improvements in immunoassay analyzers, such as the Dxl 9000 introduced by Danaher Corporation in that same year, have broadened the testing functionalities of POC devices.
Another important factor is the increasing incidence of chronic and infectious diseases, especially in areas with restricted access to centralized healthcare services. The increase in worldwide diabetes cases has driven the need for glucose monitoring devices.
Moreover, partnerships and projects focused on enhancing accessibility and affordability are influencing the market. In December 2023, Thermo Fisher Scientific collaborated with Project HOPE to enhance HIV testing services in Sub-Saharan Africa, highlighting the importance of POC diagnostics in tackling healthcare issues in underserved areas.
With healthcare systems placing greater emphasis on decentralization and at-home care, the POC diagnostics market is set to expand further, fueled by innovations, an escalating disease burden, and the demand for affordable, immediate diagnostic solutions.
Market Dynamics
Drivers
Technological innovations are one of the most significant drivers of the Point-of-Care Diagnostics Market.
Microfluidics refers to the precise control and manipulation of fluids that are geometrically constrained to a small scale, and recent progress in this area has led to the development of benchtop devices set to deliver the ability to quickly obtain results in a compact, portable format. This has transformed the healthcare domain, predominantly during emergencies, in remote locations, or low-resource settings. The incorporation of biosensors into diagnostic platforms has further improved their accuracy and sensitivity, resulting in faster and more reliable outcomes. Other technologies such as digital and mobile health platforms are expanding POC diagnostic accessibility, enabling patients to conveniently receive test results and track their health status via smartphone and wearable devices. Detailed AI-based diagnostics also revolutionize POC testing by automating data analysis, improving the precision of diagnostics, and lowering human error. These innovations are driving up the effectiveness and reduced cost of POC diagnostics which are leading to the fast uptake of POC diagnostics around the world.
The global rise in chronic conditions like diabetes, cardiovascular diseases, and respiratory disorders has been a major factor in increasing the demand for point-of-care testing.
The global rise in chronic diseases like diabetes, cardiac problems, and respiratory conditions has been a major factor in the surging demand for point-of-care testing. These conditions require continuous monitoring and management, and POC diagnostic tests are ideally suited to meet these goals. Patients can actively manage their conditions with a focus on immediate results, decreasing complication potential, and promoting quality of life. One of the examples of POC devices is the ones being used for monitoring blood glucose levels for diabetes patients that help manage better disease outcomes.
Beyond chronic diseases, the endemic spread of infectious diseases such as tuberculosis and HIV has fueled the demand for POC diagnostic solutions. Point-of-care (POC) devices offer rapid detection, allowing prompt diagnosis and treatment from healthcare professionals to patients which reduces the spread of infection and also reduces the cost of healthcare. Antimicrobial resistance (AMR) is continuing to grow and putting more attention on the use of more rapid, more targeted diagnostics at the point of care are less focused on inappropriate treatments and getting better outcomes. Rising demand for timely diagnosis & treatment in healthcare establishments and home care settings is projected to boost the point-of-care diagnostics market growth.
Restraint
One of the primary restraints limiting the growth of the Point-of-Care Diagnostics Market is the high initial cost of diagnostic devices.
The high capital cost of diagnostic devices is one of the major recycling market restraints that hinder the growth of Point-of-Care Diagnostics Market. The long-term benefits of rapid diagnosis and lower healthcare costs are clear and incredibly significant, but the upfront costs for novel point-of-care devices can be restrictive, particularly for complex and highly accurate systems. In developing parts of the world or in rural communities, budget limitations prevent the implementation of such technologies, which has become a barrier for healthcare providers. Moreover, the cost of manufacturing, followed by regulatory approvals, and finally, maintenance all add up to make these devices less affordable for smaller healthcare facilities and patients with limited financial means. These factors can hinder the broad adoption of point-of-care diagnostics, especially in resource-constrained settings.
Segment Analysis
By Product
In 2023, the blood glucose monitoring segment dominated the point-of-care diagnostics market with 54% of market share, propelled by the rising incidence of diabetes and the commitment of market participants to create innovative products utilizing advanced technologies. A notable advancement in this area was the introduction of Dexcom ONE+, an innovative Continuous Glucose Monitoring (CGM) system by Dexcom, Inc., designed to improve diabetes management for individuals in the Netherlands in Feb 2024.
The pregnancy and fertility testing segment is projected to witness significant growth throughout the forecast period, driven by increasing fertility worries and heightened awareness about sexual health. The growing use of testing kits, especially in advanced markets such as the U.S., Germany, and the U.K., is a crucial element driving the growth of this segment.
By Sample
In 2023, The blood sample segment dominated the Point-of-Care (POC) Diagnostics Market owing to its utility in providing high-quality and proof testing for a wide range of chronic and infectious diseases. With the rising incidence of diabetes, cardiovascular diseases, infections, etc., the demand for blood-based tests is expected to grow. Such tests provide rapid, on-site results and are pivotal to care during emergencies and chronic disease management. Blood sample tests are more convenient than ever, due to advancements in technology, including continuous glucose monitoring (CGM) and portable testing devices. Moreover, both patients and healthcare professionals prefer blood-based tests due to their ease of use and minimal processing time. As the market continues to shift, with the emergence of home healthcare and affordable testing, blood-based POC diagnostics will become the mainstay.
The urine sample segment is expected to significantly expand at a high CAGR during the forecast period, owing to the increasing prevalence of kidney disorders. According to 2023 data from the CDC, an estimated 35.5 million U.S. adults are estimated to have chronic kidney disease (CKD), accounting for approximately 1 in 7 adults in the country. Also, it can be used widely for the diagnosis of chronic kidney diseases (CKD) and it can be used because the prevalence of CKD has been growing significantly in recent times and is likely to increase the demand for urine-based tests which are widely used for kidney disease diagnosis. Thus, the urine segment is expected to see growth as both healthcare providers and patients look for more accessible and affordable kidney health management solutions.
Regional Analysis
North America dominated the market with 43% of market share in 2023, driven by factors including the growing geriatric population, and increased spending on healthcare. Technological advancements, including broad adoption across Picture Archiving and Communication Systems (PACS) and Electronic Medical Records (EMRs), as well as compact diagnostic toolsets that provide faster results, are some of the key drivers for this dominance. The market in the region is further driven by the presence of significant players, such as Abbott, BIOMERIEUX, BD, Siemens Healthineers AG, QIAGEN, Quidel Corporation, and Quest Diagnostics. For instance, Abbott had been granted FDA clearance for FreeStyle Libre 3 integrated continuous glucose monitoring system in the United States in April 2023, which is expected to further strengthen its stance.
Asia Pacific is projected to be one of the fastest-growing regions for the point-of-care diagnostics market with a 8.97% CAGR throughout the forecast period. This growth is driven by growing healthcare infrastructure development and the increasing prevalence of chronic and targeted diseases including diabetes and cancer and infectious diseases including HIV, Syphilis, and RSV. The need for rapid and precise results is expected to drive the demand for point-of-care diagnostics in settings such as operating rooms, emergency departments, ICUs, Pathology labs, and hospitals. Furthermore, a strong product pipeline in infectious and cardiac marker segments from the region is anticipated to provide traction to growth till 2032.
Key Market Players
Abbott (i-STAT System, FreeStyle Libre Continuous Glucose Monitoring System)
Roche Diagnostics (Accu-Chek Guide Glucometer, Cobas Liat PCR System)
Siemens Healthineers (epoc Blood Analysis System, CLINITEST Rapid COVID-19 Antigen Test)
Danaher Corporation (Cepheid GeneXpert System, HemoCue Hb 801 Hemoglobin Analyzer)
Quidel Corporation (Sofia SARS Antigen FIA, QuickVue At-Home OTC COVID-19 Test)
Becton, Dickinson, and Company (BD Veritor Plus System, BD FACSPresto Near-Patient CD4 Counter)
Cardinal Health (SureTemp Thermometer, Instra-Therm Infrared Thermometer)
BioMérieux (VIKIA Malaria Rapid Test, BIOFIRE FilmArray)
Thermo Fisher Scientific (TaqMan Point-of-Care Molecular Diagnostics, Procalcitonin (PCT) Test)
Cepheid (GeneXpert Infinity System, Xpert MTB/RIF Assay)
Nova Biomedical (StatStrip Glucose/Ketone Meter, Stat Profile Prime Plus Analyzer)
HemoCue (HemoCue Glucose 201 RT, HemoCue HbA1c 501)
OraSure Technologies (OraQuick HIV Test, OraQuick HCV Rapid Antibody Test)
EKF Diagnostics (Quo-Lab HbA1c Analyzer, DiaSpect Tm Hemoglobin Analyzer)
Accriva Diagnostics (Hemochron Signature Elite, VerifyNow System)
Chembio Diagnostics (DPP HIV-Syphilis System, STAT-PAK Assay)
Trinity Biotech (Uni-Gold HIV Test, Premier Hb9210 HbA1c Analyzer)
ARKRAY, Inc. (Glucocard Shine Blood Glucose Meter, ADAMS A1c HA-8180V Analyzer)
PTS Diagnostics (CardioChek Plus Analyzer, A1CNow+ System)
Key suppliers
Supplies diagnostic test kits and instruments like lateral flow immunoassay tests and molecular diagnostic tools
Thermo Fisher Scientific
Roche Diagnostics
Abbott Laboratories
Siemens Healthineers
Danaher Corporation
Quidel Corporation
BioMérieux
Becton, Dickinson and Company
Cepheid (a subsidiary of Danaher)
OraSure Technologies
Recent Developments
October 2023: QIAGEN announced that its IVD kit and automated testing platform, NeuMoDx, received CE certification. This achievement significantly boosted the company’s market presence and revenue, enhancing its competitive position.
May 2023: Danaher Corporation launched the Dxl 9000 Access Immunoassay Analyzer, capable of running up to 215 tests per hour. This innovation expanded the company’s point-of-care diagnostics portfolio and strengthened its market offerings.
May 2023: BD secured 510(k) clearance for its Kiestra Methicillin-resistant Staphylococcus aureus (MRSA) imaging application, which utilizes AI technology. The application accelerates test turnaround times by automating the labor-intensive process of assessing bacterial growth on Petri dishes.
December 2023: Thermo Fisher Scientific Inc. partnered with Project HOPE, a global health and humanitarian organization, to improve access to HIV testing services for youth living with HIV in Sub-Saharan Africa. This collaboration aims to enhance HIV care and treatment accessibility in the region.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | US$ 41.79 Billion |
| Market Size by 2032 | US$ 128.62 Billion |
| CAGR | CAGR of 13.27% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | •By Product (Blood Glucose Monitoring, Infectious Disease Monitoring, Cardiometabolic Disease Testing, Hematology Testing, Others) •By Sample (Blood, Nasal and Oropharyngeal Swabs, Urine, Others) •By End-User (Hospital Bedside, Physician’s Office Lab, Urgent Care & Retail Clinics, Home & Self Testing) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Abbott, Roche Diagnostics, Siemens Healthineers, Danaher Corporation, Quidel Corporation, Becton, Dickinson, and Company, Cardinal Health, BioMérieux, Thermo Fisher Scientific, Cepheid, Nova Biomedical, HemoCue, OraSure Technologies, EKF Diagnostics, Accriva Diagnostics, Chembio Diagnostics, Trinity Biotech, ARKRAY, Inc., PTS Diagnostics, and other players. |
| Key Drivers | •Technological innovations are one of the most significant drivers of the Point-of-Care Diagnostics Market. •The global rise in chronic conditions like diabetes, cardiovascular diseases, and respiratory disorders has been a major factor in increasing the demand for point-of-care testing. |
| Restraints | •One of the primary restraints limiting the growth of the Point-of-Care Diagnostics Market is the high initial cost of diagnostic devices. |
Ans- Point-of-Care Diagnostics Market was valued at USD 46.97 billion in 2023 and is expected to reach USD 91.47 billion by 2032.
Ans – The CAGR rate of the Point-of-Care Diagnostics Market during 2024-2032 is 7.72%.
Ans- The Blood Glucose Monitoring segment dominated the market by 54%.
Ans- North America held the largest revenue share by 53%.
Ans- Asia Pacific is the fastest-growing region in the Point-of-Care Diagnostics Market.
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence (2023)
5.2 Usage Trends, (2023), by Region
5.3 Device Volume by Region (2020-2032)
5.4 Technological Advancements and Market Trends
5.5 Healthcare Spending by Region (2023) (Government, Commercial, Private, Out-of-Pocket)
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Point-of-Care Diagnostics Market Segmentation, by Product
7.1 Chapter Overview
7.2 Blood Glucose Monitoring
7.2.1 Blood Glucose Monitoring Market Trends Analysis (2020-2032)
7.2.2 Blood Glucose Monitoring Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Blood Glucose Monitoring
7.3.1 Blood Glucose Monitoring Market Trends Analysis (2020-2032)
7.3.2 Blood Glucose Monitoring Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Cardiometabolic Disease Testing
7.4.1 Cardiometabolic Disease Testing Market Trends Analysis (2020-2032)
7.4.2 Cardiometabolic Disease Testing Market Size Estimates and Forecasts to 2032 (USD Billion)
7.5 Hematology Testing
7.5.1 Hematology Testing Market Trends Analysis (2020-2032)
7.5.2 Hematology Testing Market Size Estimates and Forecasts to 2032 (USD Billion)
7.6 Others
7.6.1 Others Market Trends Analysis (2020-2032)
7.6.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Point-of-Care Diagnostics Market Segmentation, by Sample
8.1 Chapter Overview
8.2 Blood
8.2.1 Blood Market Trends Analysis (2020-2032)
8.2.2 Blood Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Nasal and Oropharyngeal Swabs
8.3.1 Nasal and Oropharyngeal Swabs Market Trends Analysis (2020-2032)
8.3.2 Nasal and Oropharyngeal Swabs Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Urine
8.4.1 Urine Market Trends Analysis (2020-2032)
8.4.2 Urine Market Size Estimates and Forecasts to 2032 (USD Billion)
8.5 Others
8.5.1 Others Market Trends Analysis (2020-2032)
8.5.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Point-of-Care Diagnostics Market Segmentation, by End User
9.1 Chapter Overview
9.2 Hospital Bedside
9.2.1 Hospital Bedside Market Trends Analysis (2020-2032)
9.2.2 Hospital Bedside Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 Physician’s Office Lab
9.3.1 Physician’s Office Lab Market Trends Analysis (2020-2032)
9.3.2 Physician Office Lab Market Size Estimates and Forecasts to 2032 (USD Billion)
9.4 Urgent Care & Retail Clinics
9.4.1 Urgent Care & Retail Clinics Market Trends Analysis (2020-2032)
9.4.2 Urgent Care & Retail Clinics Market Size Estimates and Forecasts to 2032 (USD Billion)
9.5 Home & Self Testing
9.5.1 Home & Self-Testing Market Trends Analysis (2020-2032)
9.5.2 Home & Self-Testing Market Size Estimates and Forecasts to 2032 (USD Billion)
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America Point-of-Care Diagnostics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.2.3 North America Point-of-Care Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.2.4 North America Point-of-Care Diagnostics Market Estimates and Forecasts, by Sample (2020-2032) (USD Billion)
10.2.5 North America Point-of-Care Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.2.6 USA
10.2.6.1 USA Point-of-Care Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.2.6.2 USA Point-of-Care Diagnostics Market Estimates and Forecasts, by Sample (2020-2032) (USD Billion)
10.2.6.3 USA Point-of-Care Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.2.7 Canada
10.2.7.1 Canada Point-of-Care Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.2.7.2 Canada Point-of-Care Diagnostics Market Estimates and Forecasts, by Sample (2020-2032) (USD Billion)
10.2.7.3 Canada Point-of-Care Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.2.8 Mexico
10.2.8.1 Mexico Point-of-Care Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.2.8.2 Mexico Point-of-Care Diagnostics Market Estimates and Forecasts, by Sample (2020-2032) (USD Billion)
10.2.8.3 Mexico Point-of-Care Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3 Europe
10.3.1 Eastern Europe
10.3.1.1 Trends Analysis
10.3.1.2 Eastern Europe Point-of-Care Diagnostics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.1.3 Eastern Europe Point-of-Care Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.4 Eastern Europe Point-of-Care Diagnostics Market Estimates and Forecasts, by Sample (2020-2032) (USD Billion)
10.3.1.5 Eastern Europe Point-of-Care Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.1.6 Poland
10.3.1.6.1 Poland Point-of-Care Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.6.2 Poland Point-of-Care Diagnostics Market Estimates and Forecasts, by Sample (2020-2032) (USD Billion)
10.3.1.6.3 Poland Point-of-Care Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.1.7 Romania
10.3.1.7.1 Romania Point-of-Care Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.7.2 Romania Point-of-Care Diagnostics Market Estimates and Forecasts, by Sample (2020-2032) (USD Billion)
10.3.1.7.3 Romania Point-of-Care Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.1.8 Hungary
10.3.1.8.1 Hungary Point-of-Care Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.8.2 Hungary Point-of-Care Diagnostics Market Estimates and Forecasts, by Sample (2020-2032) (USD Billion)
10.3.1.8.3 Hungary Point-of-Care Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.1.9 Turkey
10.3.1.9.1 Turkey Point-of-Care Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.9.2 Turkey Point-of-Care Diagnostics Market Estimates and Forecasts, by Sample (2020-2032) (USD Billion)
10.3.1.9.3 Turkey Point-of-Care Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.1.10 Rest of Eastern Europe
10.3.1.10.1 Rest of Eastern Europe Point-of-Care Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.10.2 Rest of Eastern Europe Point-of-Care Diagnostics Market Estimates and Forecasts, by Sample (2020-2032) (USD Billion)
10.3.1.10.3 Rest of Eastern Europe Point-of-Care Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2 Western Europe
10.3.2.1 Trends Analysis
10.3.2.2 Western Europe Point-of-Care Diagnostics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.2.3 Western Europe Point-of-Care Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.4 Western Europe Point-of-Care Diagnostics Market Estimates and Forecasts, by Sample (2020-2032) (USD Billion)
10.3.2.5 Western Europe Point-of-Care Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.6 Germany
10.3.2.6.1 Germany Point-of-Care Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.6.2 Germany Point-of-Care Diagnostics Market Estimates and Forecasts, by Sample (2020-2032) (USD Billion)
10.3.2.6.3 Germany Point-of-Care Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.7 France
10.3.2.7.1 France Point-of-Care Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.7.2 France Point-of-Care Diagnostics Market Estimates and Forecasts, by Sample (2020-2032) (USD Billion)
10.3.2.7.3 France Point-of-Care Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.8 UK
10.3.2.8.1 UK Point-of-Care Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.8.2 UK Point-of-Care Diagnostics Market Estimates and Forecasts, by Sample (2020-2032) (USD Billion)
10.3.2.8.3 UK Point-of-Care Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.9 Italy
10.3.2.9.1 Italy Point-of-Care Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.9.2 Italy Point-of-Care Diagnostics Market Estimates and Forecasts, by Sample (2020-2032) (USD Billion)
10.3.2.9.3 Italy Point-of-Care Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.10 Spain
10.3.2.10.1 Spain Point-of-Care Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.10.2 Spain Point-of-Care Diagnostics Market Estimates and Forecasts, by Sample (2020-2032) (USD Billion)
10.3.2.10.3 Spain Point-of-Care Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.11 Netherlands
10.3.2.11.1 Netherlands Point-of-Care Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.11.2 Netherlands Point-of-Care Diagnostics Market Estimates and Forecasts, by Sample (2020-2032) (USD Billion)
10.3.2.11.3 Netherlands Point-of-Care Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.12 Switzerland
10.3.2.12.1 Switzerland Point-of-Care Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.12.2 Switzerland Point-of-Care Diagnostics Market Estimates and Forecasts, by Sample (2020-2032) (USD Billion)
10.3.2.12.3 Switzerland Point-of-Care Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.13 Austria
10.3.2.13.1 Austria Point-of-Care Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.13.2 Austria Point-of-Care Diagnostics Market Estimates and Forecasts, by Sample (2020-2032) (USD Billion)
10.3.2.13.3 Austria Point-of-Care Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.14 Rest of Western Europe
10.3.2.14.1 Rest of Western Europe Point-of-Care Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.14.2 Rest of Western Europe Point-of-Care Diagnostics Market Estimates and Forecasts, by Sample (2020-2032) (USD Billion)
10.3.2.14.3 Rest of Western Europe Point-of-Care Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4 Asia Pacific
10.4.1 Trends Analysis
10.4.2 Asia Pacific Point-of-Care Diagnostics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.4.3 Asia Pacific Point-of-Care Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.4 Asia Pacific Point-of-Care Diagnostics Market Estimates and Forecasts, by Sample (2020-2032) (USD Billion)
10.4.5 Asia Pacific Point-of-Care Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.6 China
10.4.6.1 China Point-of-Care Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.6.2 China Point-of-Care Diagnostics Market Estimates and Forecasts, by Sample (2020-2032) (USD Billion)
10.4.6.3 China Point-of-Care Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.7 India
10.4.7.1 India Point-of-Care Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.7.2 India Point-of-Care Diagnostics Market Estimates and Forecasts, by Sample (2020-2032) (USD Billion)
10.4.7.3 India Point-of-Care Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.8 Japan
10.4.8.1 Japan Point-of-Care Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.8.2 Japan Point-of-Care Diagnostics Market Estimates and Forecasts, by Sample (2020-2032) (USD Billion)
10.4.8.3 Japan Point-of-Care Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.9 South Korea
10.4.9.1 South Korea Point-of-Care Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.9.2 South Korea Point-of-Care Diagnostics Market Estimates and Forecasts, by Sample (2020-2032) (USD Billion)
10.4.9.3 South Korea Point-of-Care Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.10 Vietnam
10.4.10.1 Vietnam Point-of-Care Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.10.2 Vietnam Point-of-Care Diagnostics Market Estimates and Forecasts, by Sample (2020-2032) (USD Billion)
10.4.10.3 Vietnam Point-of-Care Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.11 Singapore
10.4.11.1 Singapore Point-of-Care Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.11.2 Singapore Point-of-Care Diagnostics Market Estimates and Forecasts, by Sample (2020-2032) (USD Billion)
10.4.11.3 Singapore Point-of-Care Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.12 Australia
10.4.12.1 Australia Point-of-Care Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.12.2 Australia Point-of-Care Diagnostics Market Estimates and Forecasts, by Sample (2020-2032) (USD Billion)
10.4.12.3 Australia Point-of-Care Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.13 Rest of Asia Pacific
10.4.13.1 Rest of Asia Pacific Point-of-Care Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.13.2 Rest of Asia Pacific Point-of-Care Diagnostics Market Estimates and Forecasts, by Sample (2020-2032) (USD Billion)
10.4.13.3 Rest of Asia Pacific Point-of-Care Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5 Middle East and Africa
10.5.1 Middle East
10.5.1.1 Trends Analysis
10.5.1.2 Middle East Point-of-Care Diagnostics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.1.3 Middle East Point-of-Care Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.4 Middle East Point-of-Care Diagnostics Market Estimates and Forecasts, by Sample (2020-2032) (USD Billion)
10.5.1.5 Middle East Point-of-Care Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.1.6 UAE
10.5.1.6.1 UAE Point-of-Care Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.6.2 UAE Point-of-Care Diagnostics Market Estimates and Forecasts, by Sample (2020-2032) (USD Billion)
10.5.1.6.3 UAE Point-of-Care Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.1.7 Egypt
10.5.1.7.1 Egypt Point-of-Care Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.7.2 Egypt Point-of-Care Diagnostics Market Estimates and Forecasts, by Sample (2020-2032) (USD Billion)
10.5.1.7.3 Egypt Point-of-Care Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.1.8 Saudi Arabia
10.5.1.8.1 Saudi Arabia Point-of-Care Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.8.2 Saudi Arabia Point-of-Care Diagnostics Market Estimates and Forecasts, by Sample (2020-2032) (USD Billion)
10.5.1.8.3 Saudi Arabia Point-of-Care Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.1.9 Qatar
10.5.1.9.1 Qatar Point-of-Care Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.9.2 Qatar Point-of-Care Diagnostics Market Estimates and Forecasts, by Sample (2020-2032) (USD Billion)
10.5.1.9.3 Qatar Point-of-Care Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.1.10 Rest of Middle East
10.5.1.10.1 Rest of Middle East Point-of-Care Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.10.2 Rest of Middle East Point-of-Care Diagnostics Market Estimates and Forecasts, by Sample (2020-2032) (USD Billion)
10.5.1.10.3 Rest of Middle East Point-of-Care Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.2 Africa
10.5.2.1 Trends Analysis
10.5.2.2 Africa Point-of-Care Diagnostics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.2.3 Africa Point-of-Care Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.2.4 Africa Point-of-Care Diagnostics Market Estimates and Forecasts, by Sample (2020-2032) (USD Billion)
10.5.2.5 Africa Point-of-Care Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.2.6 South Africa
10.5.2.6.1 South Africa Point-of-Care Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.2.6.2 South Africa Point-of-Care Diagnostics Market Estimates and Forecasts, by Sample (2020-2032) (USD Billion)
10.5.2.6.3 South Africa Point-of-Care Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.2.7 Nigeria
10.5.2.7.1 Nigeria Point-of-Care Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.2.7.2 Nigeria Point-of-Care Diagnostics Market Estimates and Forecasts, by Sample (2020-2032) (USD Billion)
10.5.2.7.3 Nigeria Point-of-Care Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.2.8 Rest of Africa
10.5.2.8.1 Rest of Africa Point-of-Care Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.2.8.2 Rest of Africa Point-of-Care Diagnostics Market Estimates and Forecasts, by Sample (2020-2032) (USD Billion)
10.5.2.8.3 Rest of Africa Point-of-Care Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America Point-of-Care Diagnostics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.6.3 Latin America Point-of-Care Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.4 Latin America Point-of-Care Diagnostics Market Estimates and Forecasts, by Sample (2020-2032) (USD Billion)
10.6.5 Latin America Point-of-Care Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.6.6 Brazil
10.6.6.1 Brazil Point-of-Care Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.6.2 Brazil Point-of-Care Diagnostics Market Estimates and Forecasts, by Sample (2020-2032) (USD Billion)
10.6.6.3 Brazil Point-of-Care Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.6.7 Argentina
10.6.7.1 Argentina Point-of-Care Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.7.2 Argentina Point-of-Care Diagnostics Market Estimates and Forecasts, by Sample (2020-2032) (USD Billion)
10.6.7.3 Argentina Point-of-Care Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.6.8 Colombia
10.6.8.1 Colombia Point-of-Care Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.8.2 Colombia Point-of-Care Diagnostics Market Estimates and Forecasts, by Sample (2020-2032) (USD Billion)
10.6.8.3 Colombia Point-of-Care Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.6.9 Rest of Latin America
10.6.9.1 Rest of Latin America Point-of-Care Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.9.2 Rest of Latin America Point-of-Care Diagnostics Market Estimates and Forecasts, by Sample (2020-2032) (USD Billion)
10.6.9.3 Rest of Latin America Point-of-Care Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11. Company Profiles
11.1 Thermo Fisher Scientific
11.1.1 Company Overview
11.1.2 Financial
11.1.3 Products/ Services Offered
11.1.4 SWOT Analysis
11.2 Roche Diagnostics
11.2.1 Company Overview
11.2.2 Financial
11.2.3 Products/ Services Offered
11.2.4 SWOT Analysis
11.3 Siemens Healthineers
11.3.1 Company Overview
11.3.2 Financial
11.3.3 Products/ Services Offered
11.3.4 SWOT Analysis
11.4 Danaher Corporation
11.4.1 Company Overview
11.4.2 Financial
11.4.3 Products/ Services Offered
11.4.4 SWOT Analysis
11.5 Quidel Corporation
11.5.1 Company Overview
11.5.2 Financial
11.5.3 Products/ Services Offered
11.5.4 SWOT Analysis
11.6 Becton, Dickinson, and Company
11.6.1 Company Overview
11.6.2 Financial
11.6.3 Products/ Services Offered
11.6.4 SWOT Analysis
11.7 Cardinal Health
11.7.1 Company Overview
11.7.2 Financial
11.7.3 Products/ Services Offered
11.7.4 SWOT Analysis
11.8 BioMérieux
11.8.1 Company Overview
11.8.2 Financial
11.8.3 Products/ Services Offered
11.8.4 SWOT Analysis
11.9 Thermo Fisher Scientific
11.9.1 Company Overview
11.9.2 Financial
11.9.3 Products/ Services Offered
11.9.4 SWOT Analysis
11.10 Cepheid
11.10.1 Company Overview
11.10.2 Financial
11.10.3 Products/ Services Offered
11.10.4 SWOT Analysis
12. Use Cases and Best Practices
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segments:
By Product
Blood Glucose Monitoring
Infectious Disease Monitoring
Cardiometabolic Disease Testing
Hematology Testing
Others
By Sample
Blood
Nasal and Oropharyngeal Swabs
Urine
Others
By End- User
Hospital Bedside
Physican’s Office Lab
Urgent Care & Retai Clinics
Home & Self Testing
Request for Segment Customization as per your Business Requirement: Segment Customization Request
REGIONAL COVERAGE:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of the Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization to meet the company’s specific needs. The following customization options are available for the report:
Product Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Product Matrix which gives a detailed comparison of the product portfolio of each company
Geographic Analysis
Additional countries in any of the regions
Company Information
Detailed analysis and profiling of additional market players (Up to five)
The Ion Chromatography Market Size was valued at USD 3.13 billion in 2023, and expected to reach USD 6.40 billion by 2032 and grow at a CAGR of 8.28% over the forecast period 2024-2032.
The Nano Biotechnology Market Size was valued at USD 5.65 billion in 2023 and is expected to reach USD 12.99 billion by 2032 and grow at a CAGR of 9.71% over the forecast period 2024-2032.
The Biochips Market was valued at USD 10.35 billion in 2023 and is expected to reach USD 35.00 billion by 2032, growing at a CAGR of 14.52% from 2024 to 2032.
The Breast Implants Market Size was valued at USD 3.06 Billion in 2023, and is expected to reach USD 5.34 Billion by 2032, and grow at a CAGR of 6.67%.
The Medical Tape and Bandage Market Size was valued at USD 7.80 Billion in 2023, and is expected to reach USD 11.10 Billion by 2032, and grow at a CAGR of 4.12%.
Digital X-Ray Systems Market was valued at $ 7.9 billion in 2023 and is expected to reach $ 15.4 billion by 2032 and grow at a CAGR of 7.8% from 2024 to 2032.
Hi! Click one of our member below to chat on Phone
© 2025 All Rights Reserved by SNS Insider Pvt Ltd
